Ultrasound-Guided Percutaneous Radiofrequency for the Treatment of Morton’s Neuroma
- 456 Downloads
Morton’s neuroma (MN) is a leading cause of disability. The purpose of this study was to investigate the effectiveness of radiofrequency (RF) in patients with chronic pain refractory to conservative therapies.
Between September 2012 and December 2016, RF was performed on 52 patients. A sterile RF needle probe (22G, 5-cm needle with 10-mm electrode active tip) was inserted between the toes into the intermetatarsal space at the center of the lesion. Potential complications of the intervention and post-procedure care were examined. All patients provided written, informed consent. All percutaneous procedures were performed with the NeuroTherm® NT1100 (Neurotherm Inc., M.) device and using ultrasound guidance (Philips IU22). Continuous RF was performed with one cycle of 90 s and with the probe tip maintaining a temperature of 85 °C (impedance 95–210 mΩ).
Mean VAS score before the procedures was 9.0 ± 0.6. A reduction of pain intensity was achieved after 1 week by RF (mean VAS scores 3.7 ± 0.9; p < 0.05), with a stabilization of the painful symptomatology in the following months and after 1 year of treatments (mean VAS scores 2.0 ± 0.4 after 12 months, p < 0.05). The FHSQ scores showed improved quality of life (QOL) in all patients at 6 months (p < 0.05) and 1 year (p < 0.05) of RF. No patients developed complications.
RF is a safe, efficient, and minimally invasive technique for the treatment of symptomatic MN.
KeywordsMorton’s neuroma Foot pain Radiofrequency Chronic pain
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Thomson CE, Gibson JN, Martin D. Interventions for the treatment of Morton’s neuroma. Cochrane Database Syst Rev. 2004;3:CD003118.Google Scholar
- 2.Greenfield J, Rea J Jr, et al. Morton’s interdigital neuroma. Indications for treatment by local surgery. Clin Orthop Relat Res. 1984;185:142–4.Google Scholar
- 5.Couglin MJ, Mann RA, Saltzmann CL. Surgery of the foot and ankle. 8th ed. Amsterdam: Mosby Elsevier; 2006. p. 614–34.Google Scholar
- 9.Sirera-Vercher MJ, Sàez-Zamora P, Sanz-Amaro MD. Traducción y adaptación transcultural al castellano y al valenciano del Foot Health Status Questionnaire. Rev Esp Cir Ortop Traumatol. 2010;54(4):211–9.Google Scholar
- 11.Bennett PJ, Patterson C. The Foot Health Status Questionnaire (FHSQ): a new instrument for measuring outcomes of footcare. AJPM Orig Res. 1998;32(3):87–92.Google Scholar
- 13.Lelievre J, Lelievre JF. Pathologie du Pied. Paris: Masson; 1981.Google Scholar
- 14.Gauthier G. Thomas Morton’s disease: a nerve entrapment syndrome. A new surgical technique. Clin Orthop. 1979;142:90–2.Google Scholar
- 21.Greenfield J, Rea J Jr, Ilfeld FW. Morton’s interdigital neuroma: indications for treatment by local injection surgery. Clin Orthop Relat Res. 1984;185:142–4.Google Scholar
- 26.Cazzato PL, Garnon J, Ramamurthy N, Tsoumakidou G, Caudrelier J, Thenint M-A, Rao P, Koch G, Gangi A. Percutaneous MR-guided cryoablation of Morton’s neuroma: rationale and technical details after the first 20 patients. Cardiovasc Intervent Radiol. 2016. doi: 10.1007/s00270-016-1365-7.Google Scholar